Xinhao Li
Senior Scientist II, In Silico Discovery Johnson & Johnson
Bio Dr. Xinhao Li is a Senior Scientist II at Johnson & Johnson Innovative Medicine, specializing in machine learning and cheminformatics. He develops computational platforms and AI/ML models for targeted protein degradation and small molecule drug discovery.
Seminars
Thursday 19th March 2026
DELTA (Decompose, Enumerate, Library, Transform, Atlas): The Computational Toolkit for Targeted Protein Degradation
2:30 pm
- Showcase DELTA as an integrated, modular platform that accelerates targeted protein degradation (TPD) research
- Address how DELTA streamlines PROTAC design and optimization through systematic decomposition, enumeration, library curation, and computational profiling
- Share how DELTA integrates medicinal chemistry expertise with advanced computational analysis to deliver comprehensive, data-driven insights that support confident decision-making
